Dyne Therapeutics Company
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Connections from
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Founded Date:
1/1/2018
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50
Total Funding:
333000000
Industry:
PharmTech